Turn Therapeutics (TTRX) Current Leases (2024 - 2026)

Turn Therapeutics has reported Current Leases for 3 years, with the latest figure at $47795.0 in Q1 2026.

• For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $47795.0; the trailing twelve-month figure through Mar 2026 stood at $47795.0 (changed N/A YoY), and the FY2025 full-year result was $46295.0, up 13.86% from the prior year.
• Current Leases for Q1 2026 stood at $47795.0, up from $46295.0 in the prior quarter.
• The five-year high for Current Leases was $47795.0 in Q1 2026, with the low at $40660.0 in Q4 2024.
• Average Current Leases over 3 years is $44894.8, with a median of $45562.0 recorded in 2025.
• Peak annual rise in Current Leases reached 13.86% in 2025, while the deepest fall reached 13.86% in 2025.
• Tracing TTRX's Current Leases over 3 years: stood at $40660.0 in 2024, then increased by 13.86% to $46295.0 in 2025, then grew by 3.24% to $47795.0 in 2026.
• The last three Current Leases figures came in at $47795.0 (Q1 2026), $46295.0 (Q4 2025), and $44829.0 (Q3 2025), per Business Quant data.

Peer Comparison